|Own your ow legal marijuana business||
Your guide to making money in the multi-billion dollar marijuana industry
|Carl Olsen's Marijuana Archive|
NATIONAL ORGANIZATION FOR THE REFORM OF MARIJUANA LAWS
1001 CONNECTICUT AVENUE NW
T 202-483-5500 F
202-483-0057 E-MAIL NATLNORML@AOL.COM
. . . a weekly service for the media on news items related to Marijuana Prohibition.
February 13, 1997
NORML, Others Respond To
Upcoming NIDA Conference
On Medical Marijuana
February 13, 1996, Washington, D.C.:
The National Institute on Drug Abuse (NIDA) is convening a
two-day conference next week to assess existing scientific
research regarding marijuana's therapeutic potential. The
conference was announced following public criticism from some
members of the medical establishment over the Administration's
refusal to allow physicians to prescribe marijuana for seriously
ill patients in accordance with recently passed state initiatives
in Arizona and California. The conference will take place
on February 19 and 20.
National Institute of Health officials claim that the conference will remain solely scientific in nature, and Drug Czar General Barry McCaffrey has publicly stated that he does not expect to attend the conference. However, many medical marijuana proponents remain doubtful that the conference will remain devoid of politics.
"It seems ironic that the same federal agency that has twice denied the marijuana necessary to conduct an FDA-approved protocol by San Francisco researcher Dr. Donald Abrams on the effects of marijuana and the AIDS wasting syndrome, and has stonewalled proposed state-sponsored medical marijuana studies by both Washington State University and the Massachusetts Department of Health will be an objective moderator for this scientific review," said NORML's Deputy Director Allen St. Pierre. He announced that NORML, in conjunction with other Washington D.C.-based drug-law reform organizations, will be holding a press conference on Wednesday, February 19, where doctors and patients will speak in favor of marijuana's medical value. Dr. John Morgan of City University of New York Medical School, NORML Board Member Lynn Zimmer, Ph.D., of Queens College, and former medical marijuana user Richard Brookhiser -- Senior Editor of National Review -- are expected to speak the press conference, along with various medical marijuana patients.
Medical marijuana proponents will present NIDA officials with a compendium of over 75 scientific studies demonstrating marijuana's medical effectiveness in the treatment of glaucoma, spasticity disorders, the nausea associated with cancer chemotherapy, and other serious illnesses. Included in the compendium are the results of several state-sponsored clinical trials involving hundreds of patients. For example, a 1983 report evaluating the effects of marijuana as an anti-emetic in cancer patients released by Tennessee Board of Pharmacy concluded: "We found both marijuana smoking and THC capsules to be effective anti-emetics. We found an approximate 23 percent higher success rate among those patients smoking than among those patients administered THC capsules." [Emphasis added. --ed.]
"Contrary to popular belief, there have been hundreds of studies on the medical uses of cannabis since its introduction to western medicine in the mid-nineteenth century," said NORML's Publications Director Paul Armentano who attended NIDA's 1995 National Conference on Marijuana Use: Prevention, Treatment, and Research. He noted that the subject of medical marijuana was effectively "swept under the rug" during that forum. "NIDA had the opportunity to address this pressing issue in 1995, but opted to all but ignore the issue, allotting less than one half-hour for its discussion," Armentano explained.
"The literature [in support of medical marijuana] has been there a long time," Dr. Laurens White, a cancer specialist in San Francisco, told the New York Times. "There is enough anecdotal evidence and papers to say that medically, there isn't any evidence of harm and that there is evidence of benefit."
For more information, please call Allen St. Pierre of NORML @ (202) 483-5500 or Dave Fratello of Americans for Medical Rights @ (202) 537-5005. Copies of NORML's position paper: Making The Case For Medical Marijuana, are available upon request or on-line at NORML's website at: http://www.norml.org.
(Meanwhile) Senators Introduce Anti-Medical Marijuana Bill In Congress
February 13, 1996, Washington, D.C.:
Rep. Lauch Faircloth (R-N.C.) has introduced legislation in
Congress (S. 40) to severely sanction physicians who recommend
the medical use of marijuana to seriously ill patients. The
measure appears to be a direct response to the November passage
of a California ballot initiative granting an affirmative medical
defense under state law for patients who use marijuana
medicinally with the recommendation of their physician. The
California proposition also states that, "Physicians shall
not be punished or denied any right or privilege for recommending
marijuana to a patient for medical purposes.
Federal law already forbids doctors from prescribing marijuana.
"This legislation represents the most extreme position of those who oppose the medical use of marijuana -- arresting and jailing physicians," said NORML's Executive Director R. Keith Stroup. He noted that doctors who recommend marijuana to a patient under 21 years of age may be sentenced to up to eight years in prison and/or fined $60,000 under the provisions of the bill. Other penalties include revoking physicians' ability to write prescriptions and excluding doctors from participation in Medicare and state health care programs.
The proposed legislation states that, "A practitioner will be deemed to have 'recommended' the use of marihuana if the practitioner offered advice, or responded to a request for advice, suggesting the use of marihuana while acting in the course of his or her professional capacity."
Graham Boyd, an attorney from California who is representing a group of physicians and patients that have filed a class action suit against the federal government for its issuance of similar threats against doctors who recommend marijuana, calls such restrictions illegal. "The Supreme Court has said that the government may not bar physicians from discussing contraception or abortion, both controversial topics in their day," he stated in a January 15 press release. "By the same logic, federal officials may not use controversy over marijuana as an excuse to intrude on the sanctity of the physician-patient relationship."
Sens. Jesse Helms (R-N.C.) and James Inhofe (R-Okla.) are co-sponsoring the legislation, entitled the "Drug Use Prevention Act of 1997." The measure has been referred to the Senate Judiciary Committee.
For more information, please contact R. Keith Stroup, Esq., of NORML @ (202) 483-5500. Copies of the legislation are available from NORML upon request.
Drug Czar Rejects Offer To Settle Medical Marijuana Lawsuit
February 11, 1997, Washington, D.C.:
The Office of National Drug Control Policy (ONDCP) repeated its
position this past Monday that doctor's in California cannot
evade federal drug laws "by claiming that they are merely
providing their patients with 'recommendations' in accordance
with their best medical judgment." The announcement
was a response to a class action suit filed in federal court by
physicians, patients, and a San Francisco prosecutor who has
AIDS, seeking an injunction to prevent federal officials from
taking any punitive action against physicians who recommend the
medical use of marijuana to their patients in compliance with
According to Associated Press, plaintiffs offered to settle the federal case if the government would agree to bar prosecution of doctors who, in good faith, discuss the use of medical marijuana or recommend it for their patients.
"It's a straight-forward First Amendment case," said Graham Boyd, an attorney for the plaintiffs. "The First Amendment protects the rights of doctors and patients to talk about the full range of medical treatment, and the feds have no basis for interfering with that statement."
Drug Czar Barry McCaffrey said that he will reconsider his view of medical marijuana if health professionals determine it is effective, during a speech at the John F. Kennedy School of Government at Harvard University last evening.
For more information, please contact Allen St. Pierre of NORML @ (202) 483-5500 or Bill Zimmerman of Americans for Medical Rights @ (310) 394-2952.
MORE THAN 10 MILLION MARIJUANA ARRESTS SINCE 1965 . . . ANOTHER EVERY 54 SECONDS!
Schaffer Library of Drug Policy
Major Studies of Drug and Drug Policy
Marihuana, A Signal of Misunderstanding - The Report of the US National Commission on Marihuana and Drug Abuse
Licit and Illicit Drugs
Short History of the Marijuana Laws
The Drug Hang-Up
Congressional Transcripts of the Hearings for the Marihuana Tax Act of 1937
Frequently Asked Questions About Drugs
Basic Facts About the Drug War
Charts and Graphs about Drugs
Information on Alcohol
Guide to Heroin - Frequently Asked Questions About Heroin
LSD, Mescaline, and Psychedelics
Drugs and Driving
Children and Drugs
Drug Abuse Treatment Resource List
American Society for Action on Pain
Let Us Pay Taxes
Marijuana Business News
Reefer Madness Collection
Medical Marijuana Throughout History
Drug Legalization Debate
Legal History of American Marijuana Prohibition
Marijuana, the First 12,000 Years
DEA Ruling on Medical Marijuana
Legal References on Drugs
GAO Documents on Drugs
Response to the Drug Enforcement Agency
|Drug Information Articles|
Taking a drug test:
How To Pass A Drug Test
Beat Drug Test
Pass Drug Test
Drug Screening Tests
Drug Addiction Treatment